Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1983 Jul-Aug;56(4):293–301.

The effect of endotoxin and endotoxin tolerance on inflammation induced by mycobacterial adjuvant.

J T Rosenbaum, R B Mandell
PMCID: PMC2589639  PMID: 6670292

Abstract

Peptidoglycan, the substance in mycobacteria thought to be responsible for inducing adjuvant arthritis, and endotoxin (lipopolysaccharide or LPS) share many inflammatory properties. Since repeated administration of LPS produces tolerance, i.e., resistance to the toxic and inflammatory effects of LPS, we tested whether LPS and/or LPS tolerance might influence inflammation due to mycobacterial adjuvant. Male Sprague-Dawley rats were injected with Escherichia coli LPS or saline intraperitoneally and then challenged with 100 micrograms killed Mycobacteria butyricum (adjuvant) in the footpad. A single dose of 100 micrograms LPS three or 24 hours before adjuvant markedly, but transiently, reduced the local footpad swelling that begins within hours of the adjuvant injection and histologically resembles a sterile abscess. Animals that received multiple doses of LPS and were therefore tolerant or animals that received LPS 72 hours before adjuvant demonstrated adjuvant-induced footpad swelling nearly equal to controls. The anti-inflammatory effect of LPS was transient since footpad swelling in all groups was nearly comparable six days after the adjuvant injection and LPS failed to inhibit consistently the arthritis that develops two or more weeks after adjuvant injection. These studies establish that LPS can markedly inhibit the prodrome of adjuvant arthritis (footpad swelling due to M. butyricum), that inhibition of this prodrome does not prevent the subsequent development of arthritis, and that LPS tolerance diminishes this anti-inflammatory effect of LPS.

Full text

PDF
293

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown J. H., Schwartz N. L., Mackey H. K., Murray H. L. Prophylactic effects of cyclophosphamide in adjuvant-induced arthritis. Arch Int Pharmacodyn Ther. 1970 Jan;183(1):1–11. [PubMed] [Google Scholar]
  2. COHN Z. A. Determinants of infection in the peritoneal cavity. II. Factors influencing the fate of Staphylococcus aureus in the mouse. Yale J Biol Med. 1962 Aug;35:29–47. [PMC free article] [PubMed] [Google Scholar]
  3. CONTI C. R., CLUFF L. E., SCHEDER E. P. Studies on the pathogenesis of staphylococcal infection. IV. The effect of bacterial endotoxin. J Exp Med. 1961 May 1;113:845–860. doi: 10.1084/jem.113.5.845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Calin A., Fries J. F. An "experimental" epidemic of Reiter's syndrome revisited. Follow-up evidence on genetic and environmental factors. Ann Intern Med. 1976 May;84(5):564–566. doi: 10.7326/0003-4819-84-5-564. [DOI] [PubMed] [Google Scholar]
  5. Cousins S. W., Rosenbaum J. T., Guss R. B., Egbert P. R. Ocular albumin fluorophotometric quantitation of endotoxin-induced vascular permeability. Infect Immun. 1982 May;36(2):730–736. doi: 10.1128/iai.36.2.730-736.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dahinden C., Galanos C., Fehr J. Granulocyte activation by endotoxin. I. Correlation between adherence and other granulocyte functions, and role of endotoxin structure on biologic activity. J Immunol. 1983 Feb;130(2):857–862. [PubMed] [Google Scholar]
  7. Dinarello C. A., Elin R. J., Chedid L., Wolff S. M. The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues. J Infect Dis. 1978 Dec;138(6):760–767. doi: 10.1093/infdis/138.6.760. [DOI] [PubMed] [Google Scholar]
  8. Fantone J. C., Kunkel S. L., Ward P. A., Zurier R. B. Suppression by prostaglandin E1 of vascular permeability induced by vasoactive inflammatory mediators. J Immunol. 1980 Dec;125(6):2591–2596. [PubMed] [Google Scholar]
  9. GILBERT V. E., BRAUDE A. I. Reduction of serum complement in rabbits after injection of endotoxin. J Exp Med. 1962 Oct 1;116:477–490. doi: 10.1084/jem.116.4.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. HUMPHREY J. H. The mechanism of Arthus reactions. I. The role of polymorphonuclear leucocytes and other factors in reversed passive Arthus reactions in rabbits. Br J Exp Pathol. 1955 Jun;36(3):268–282. [PMC free article] [PubMed] [Google Scholar]
  11. Holoshitz J., Naparstek Y., Ben-Nun A., Cohen I. R. Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science. 1983 Jan 7;219(4580):56–58. doi: 10.1126/science.6336851. [DOI] [PubMed] [Google Scholar]
  12. Honda H., Fukawa K., Sawabe T. Influence of adjuvant arthritis on main urinary metabolites of prostaglandin F and E in rats. Prostaglandins. 1980 Feb;19(2):259–269. doi: 10.1016/0090-6980(80)90024-6. [DOI] [PubMed] [Google Scholar]
  13. Kimball H. R., Melmon M. L., Wolff S. M. Endotoxin-induced kinin production in man. Proc Soc Exp Biol Med. 1972 Mar;139(3):1078–1082. doi: 10.3181/00379727-139-36302. [DOI] [PubMed] [Google Scholar]
  14. Kohashi O., Pearson C. M., Watanabe Y., Kotani S., Koga T. Structural requirements for arthritogenicity of peptidoglycans from Staphylococcus aureus and Lactobacillus plant arum and analogous synthetic compounds. J Immunol. 1976 Jun;116(6):1635–1639. [PubMed] [Google Scholar]
  15. Kurland J. I., Bockman R. Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages. J Exp Med. 1978 Mar 1;147(3):952–957. doi: 10.1084/jem.147.3.952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Latour J. G., McKay D. G. Requirement of the adrenal glands for provocation of the generalized Shwartzman reaction. Lab Invest. 1970 Apr;22(4):281–285. [PubMed] [Google Scholar]
  17. MEIER R., BEIN H. J., JAQUES R. The action of bacterial polysaccharides on allergic phenomena. Int Arch Allergy Appl Immunol. 1957;11(1-2):101–118. doi: 10.1159/000228406. [DOI] [PubMed] [Google Scholar]
  18. MILES A. A., NIVEN J. S. F. The enhancement of infection during shock produced by bacterial toxins and other agents. Br J Exp Pathol. 1950 Feb;31(1):73–95. [PMC free article] [PubMed] [Google Scholar]
  19. Magliulo E., Scevola D., Fumarola D., Vaccaro R., Bertotto A., Burberi S. Clinical experience in detecting endotoxemia with the limulus test in typhoid fever and other Salmonella infections. Infection. 1976;4(2):21–24. doi: 10.1007/BF01638343. [DOI] [PubMed] [Google Scholar]
  20. Morrison D. C., Ryan J. L. Bacterial endotoxins and host immune responses. Adv Immunol. 1979;28:293–450. doi: 10.1016/s0065-2776(08)60802-0. [DOI] [PubMed] [Google Scholar]
  21. PEARSON C. M., WAKSMAN B. H., SHARP J. T. Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. V. Changes affecting the skin and mucous membranes. Comparison of the experimental process with human disease. J Exp Med. 1961 Mar 1;113:485–510. doi: 10.1084/jem.113.3.485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Parant M. A., Audibert F. M., Chedid L. A., Level M. R., Lefrancier P. L., Choay J. P., Lederer E. Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs. Infect Immun. 1980 Mar;27(3):826–831. doi: 10.1128/iai.27.3.826-831.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Peavy D. L., Baughn R. E., Musher D. M., Musher D. M. Effects of BCG infection on the susceptibility of mouse macrophages to endotoxin. Infect Immun. 1979 Apr;24(1):59–64. doi: 10.1128/iai.24.1.59-64.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rosenbaum J. T., McDevitt H. O., Guss R. B., Egbert P. R. Endotoxin-induced uveitis in rats as a model for human disease. Nature. 1980 Aug 7;286(5773):611–613. doi: 10.1038/286611a0. [DOI] [PubMed] [Google Scholar]
  25. Rosenbaum J. T. Why HLA-B27: an analysis based on two animal models. Ann Intern Med. 1981 Feb;94(2):261–263. doi: 10.7326/0003-4819-94-2-261. [DOI] [PubMed] [Google Scholar]
  26. SHILO M., WOLMAN B. Activities of bacterial levans and of lipopolysaccharides in the processes of inflammation and infection. Br J Exp Pathol. 1958 Dec;39(6):652–660. [PMC free article] [PubMed] [Google Scholar]
  27. SUTER E., ULLMAN G. E., HOFFMAN R. G. Sensitivity of mice to endotoxin after vaccination with BCG (Bacillus Calmette-Guérin). Proc Soc Exp Biol Med. 1958 Oct;99(1):167–169. doi: 10.3181/00379727-99-24282. [DOI] [PubMed] [Google Scholar]
  28. Shen S. M., Rapaport S. I., Feinstein D. I. Intravascular clotting after endotoxin in rabbits with impaired intrinsic clotting produced by a factor VIII antibody. Blood. 1973 Oct;42(4):523–534. [PubMed] [Google Scholar]
  29. Skidmore B. J., Chiller J. M., Morrison D. C., Weigle W. O. Immunologic properties of bacterial lipopolysaccharide (LPS): correlation between the mitogenic, adjuvant, and immunogenic activities. J Immunol. 1975 Feb;114(2 Pt 2):770–775. [PubMed] [Google Scholar]
  30. Stuart M. J. Effect of endotoxin on arachidonic acid release and thromboxane B2 production by human platelets. Am J Hematol. 1981 Sep;11(2):159–164. doi: 10.1002/ajh.2830110207. [DOI] [PubMed] [Google Scholar]
  31. Verghese M. W., Snyderman R. Differential anti-inflammatory effects of LPS in susceptible and resistant mouse strains. J Immunol. 1981 Jul;127(1):288–293. [PubMed] [Google Scholar]
  32. WOLFF S. M., MULHOLLAND J. H., WARD S. B. QUANTITATIVE ASPECTS OF THE PYROGENIC RESPONSE OF RABBITS TO ENDOTOXIN. J Lab Clin Med. 1965 Feb;65:268–275. [PubMed] [Google Scholar]
  33. WOOD F. D., PEARSON C. M. Protection of rats against adjuvant arthritis by bacterial lipoplysaccharides. Science. 1962 Aug 17;137(3529):544–545. doi: 10.1126/science.137.3529.544. [DOI] [PubMed] [Google Scholar]
  34. Wahl L. M., Olsen C. E., Sandberg A. L., Mergenhagen S. E. Prostaglandin regulation of macrophage collagenase production. Proc Natl Acad Sci U S A. 1977 Nov;74(11):4955–4958. doi: 10.1073/pnas.74.11.4955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Wahl S. M., Wahl L. M., McCarthy J. B., Chedid L., Mergenhagen S. E. Macrophage activation by mycobacterial water soluble compounds and synthetic muramyl dipeptide. J Immunol. 1979 Jun;122(6):2226–2231. [PubMed] [Google Scholar]
  36. Wildfeuer A., Heymer B., Schleifer K. H., Haferkamp O. Investigations on the specificity of the Limulus test for the detection of endotoxin. Appl Microbiol. 1974 Nov;28(5):867–871. doi: 10.1128/am.28.5.867-871.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES